BMS, “Targeted combination therapies are the best for cancer patients”

Published: 2016-11-18 10:55:34

Updated: 2016-11-18 10:55:34

BMS Pharmaceutical recommended combined targeted therapies as the best treatment for cancer patients, and announced a plan to continue and extend researches related to this.

On the 16^th, BMS Pharmaceutical Korea revealed the BMS’s development process of targeted therapies and pipelines for specialty care diseases in the ‘’2016 BMS Media R&D Day’ on the 16^th.

Shinta Cheng, MD, PhD, who takes...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.